ADB-5'Br-BUTINACA explained
Iupac Name: | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-5-bromo-1-butylindazole-3-carboxamide |
Width: | 200px |
Pubchem: | 168322646 |
Chemspiderid: | 115005697 |
Smiles: | NC(=O)[C@@H](NC(=O)c1nn(CCCC)c2ccc(Br)cc21)C(C)(C)C |
C: | 18 |
H: | 25 |
Br: | 1 |
N: | 4 |
O: | 2 |
Stdinchi: | 1S/C18H25BrN4O2/c1-5-6-9-23-13-8-7-11(19)10-12(13)14(22-23)17(25)21-15(16(20)24)18(2,3)4/h7-8,10,15H,5-6,9H2,1-4H3,(H2,20,24)(H,21,25)/t15-/m1/s1 |
Stdinchikey: | DIOILIVJIIJFPO-OAHLLOKOSA-N |
ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug,[1] first detected in Philadelphia in the US in May 2022,[2] and subsequently found in South Korea,[3] Portugal and Sweden.[4] It is specifically listed as an illegal drug in Italy,[5] South Korea[6] and several states in the US,[7] [8] and controlled under analogue legislation in various other jurisdictions.
See also
Notes and References
- Deventer MH, Persson M, Norman C, Liu H, Connolly MJ, Daéid NN, McKenzie C, Gréen H, Stove CP . In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs . Drug Testing and Analysis . October 2023 . 37903509 . 10.1002/dta.3592 . 264671035 .
- Web site: ADB-5'Br-BINACA . CFSRE Chemistry Report . The Center for Forensic Science Research & Education .
- Kim J, Yum H, Kang S, Lee N, Song J, Park Y, Choe S, Park M . Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022 . Forensic Science International . 353 . 111877 . November 2023 . 37989071 . 10.1016/j.forsciint.2023.111877 . 265022768 .
- Web site: Yttrande enligt 13 § Lag (2011:111) om förstörande av vissa hälsofarliga missbrukssubstanser . Opinion according to § 13 Act (2011:111) on the destruction of certain substances of abuse dangerous to health . sv. The Public Health Authority .
- Web site: Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella Tabella I di nuove sostanze psicoattive. (23A01072) . Update of the tables containing the indication of the substances narcotic and psychotropic drugs, referred to in the decree of the President of the Republic 9 October 1990, n. 309 and subsequent amendments e integrations. Inclusion of new substances in Table I psychoactive. (23A01072). Ministry of Health . Italy . 13 February 2023 . it .
- Web site: ˝에이디비-5'비알-부티나카˝ 등 3종 임시마약류 지정예고 . Korean Food and Drug Daily News . Announcement of temporary designation of 3 types of narcotics, including “ADB-5 ‘BR-Butinaka’” . Korean .
- Web site: 18VAC110-20-322. Placement of chemicals in Schedule I. . Administrative Code . Commonwealth of Virginia .
- Web site: Section 19-03.1-05 - Schedule I, N.D. Cent. Code § 19-03.1-05 . North Dakota Century Code .